Upload
hans
View
63
Download
4
Tags:
Embed Size (px)
DESCRIPTION
Expanding Pharmacy Services in a Health-System Primary Care Clinic: Factors to Consider. Andrea Lee, PharmD PGY2 Health-System Pharmacy Administration Resident. Objectives. Identify methods to justify the expansion of sustainable primary care pharmacy services in a health-system clinic. . - PowerPoint PPT Presentation
Citation preview
Expanding Pharmacy Services in a Health-System Primary Care Clinic: Factors to Consider
Andrea Lee, PharmDPGY2 Health-System Pharmacy
Administration Resident
Objectives Identify methods to justify the expansion of
sustainable primary care pharmacy services in a health-system clinic.
Penobscot Community Health Care (PCHC) is a Patient Centered Medical Home serving over 60,000 patients annually at 16 practice sites– Totaling over 350,000 patient visits– 70% of patients are lower income
Largest and most comprehensive Federally Qualified Health Center (FQHC) in Maine– Shared Savings Accountable Care Organization (ACO)– Previously in a Pioneer ACO- 2013– Rural health care facility providing comprehensive health care services to the
greater Bangor area and surrounding communities
Health-Care Facility
Image: www.visitmaine.org
Outpatient Pharmacy Background Three Outpatient Pharmacies– Roughly 80,000 prescriptions annually– Hours of Operation vary among
locations• One pharmacy open weekday evenings and
weekends starting October 2012
3 Full-time Pharmacists– Focus of time spent in dispensing roles
Clinical Pharmacy Services Background
Two* Clinical Pharmacists- Husson University Faculty Four PGY1 Community Pharmacy Residents
– 75% of time in clinics, 25% of time dispensing– Program developed in 2011
Clinical participation from pharmacists within the integrated team is limited to Husson Faculty presence and resident rotation within practice sites– Current services include clinical consults, chart reviews, joint patient visits with
primary care provider (PCP) Administrators desire increased clinical pharmacy services within the
organization
New Position Proposal Pharmacy Business Model Innovation– Service Design:
• 0.6 FTE – Pharmacy Staffing at Helen Hunt Health Center (HHHC) Pharmacy in Old Town, ME
• 0.4 FTE – Clinical Pharmacy Integration conducting reimbursable patient visits
– Allows for expansion of outpatient pharmacy hours in another location
– Adds a desired imbedded clinical component
Benefits of the Proposed Position1. Increased access to outpatient pharmacy services for Walk-in-Care
Patients2. Increased capture rate on new and refilled prescriptions 3. Improved oversight and documentation of continuity of care 4. Increased pharmacy presence within practice sites5. Increased patient satisfaction and efficiency of the care experience6. Increased touches on Medicare patients7. Improved student/resident education
Overview of the Landscape in Old Town, ME
Pharmacy Locations– 3 pharmacies within 5 mile
radius of health center Walk-In-Care (WIC) Locations
– HHHC is the only WIC open Weekends
– EMMC Orono no longer provides WIC services (Sat Appts only)
– UMaine Cutler Health Center- Mon-Fri only
Hours of Operation for Outpatient Pharmacy Extended Hours- HHHC
Current Hours Monday- Friday
8:30am – 5:00 pm
Staffing: 1 FTE (40hr)
Proposed Hours Monday-Friday
8:30am – 8:00pm Saturday
9:00am – 4:00pm
Staffing: 1.6 FTE (67hr)
Historical Perspective on Extended Hours Brewer location began extended hours October 2012
– Staffing component for PGY1 residents
1/7/2
012
1/26/2012
2/14/2
012
3/4/2
012
3/23/2
012
4/11/2
012
4/30/2
012
5/19/2
012
6/7/2
012
6/26/2
012
7/15/2
012
8/3/2
012
8/22/2012
9/10/2
012
9/29/2012
10/18/2
012
11/6/2
012
11/25/2
012
12/14/2
012
1/2/2
013
1/21/2
013
2/9/2
013
2/28/2
013
3/19/2
013
4/7/2
013
4/26/2
013
5/15/2
013
6/3/2
013
6/22/2
013
7/11/2
013
7/30/2
013
8/18/2013
9/6/2
013
9/25/2
013
10/14/2
013
11/2/2
013
11/21/2
013
12/10/2
013
12/29/2
013
1/17/2
014
2/5/2
014
2/24/2
014
3/15/2
014
4/3/2
0140
100
200
300
400
500
600
700
800
f(x) = 0.406247576718317 x − 16300.6305704516
Brewer Totals
TOTAL Linear (TOTAL) NEW REFILL
Trends at Brewer Pharmacy – Extended Hours
Average Monthly Fill2012 182.32013 258.82014 295.5
Average Montly Fill2012 112.66672013 111.252014 136
Analysis of Brewer Pharmacy, cont. Change in Patient Perception
– Knowing that the pharmacy is open nights and weekends as a driver for growth
– Objective Measure: Volume of refilled prescriptions filled during extended hours
Average Capture Rates of WIC RX’s around 40%– Varies by day, provider in
WIC
Extrapolation to HHHC PharmacyFINANCIAL IMPLICATIONS
Additional Cost/Year to Extend Hours $177,242.00
– Includes salary, fringe, direct expenses, administration fees
Requires approximately 5550 additional prescriptions to break even 13% rate in growth needed
Market Analysis- Questions to Consider– What is the WIC volume at HHHC in terms of Brewer?– What is the pharmacy’s current capture rate of prescriptions coming out of clinic?
Trends in Pharmacy Totals
Background on Medicare Annual Wellness Visit (AWV)
Fully paid for by Medicare Part B for beneficiaries 65 and older– No cost to eligible beneficiaries
Focused visit on “Health Risk Assessment (HRA)” – Health prevention– Disease detection– Coordination of screening
Pharmacists across the country have performed AWVs Centers for Medicare and Medicaid Services. Providing the annual wellness visit (AWV). www.cms.gov/
Billing for Annual Wellness VisitHCPCS Codes
Billing Code Descriptors Reimbursement (FFS Maximum Rate)
G0402 Initial preventative physical examination (IPPE); face-to-face visit, services limited to new beneficiary during the first 12 months of Medicare enrollment
Provider Required
G0438 Annual wellness visit (AWV); includes a personalized prevention plan of service (PPPS), initial visit
$159.38
G0439 Annual wellness visit (AWV); includes a personalized prevention plan of service (PPPS), subsequent visit
$106.35
AWV eligible for Medicare beneficiaries 66 years and older Subsequent visits billable every year
Centers for Medicare and Medicaid Services. Providing the annual wellness visit (AWV). www.cms.gov/Warshany K et al. Am J Health Syst Pharm. 2014 Jan 1;71(1):44-9.
Benefits to the Organization Utilization Drivers– Increase vaccinations (~1.25 vaccinations recommended
per person, ~30% received vaccinations at time of visit)– Referrals for additional services; ie. lab, podiatry, dietitian,
PT, audiology, mental health (~1 referral placed per patient)– Opportunities to improve quality metrics
• Patient’s accessing electronic portal
• Focus on a specific metric requiring improvement (eg. Mammogram, colonoscopy)
Feasibility of AWV Proposal 5510 Medicare Beneficiaries 66 years and older at PCHC
practice sites Pharmacist to see 13 patients each week Estimated Net Revenue $5,435 per year Factors to consider
– No show rates ~33% within institution– Start-up costs– Marketing of services– Provider and patient buy-in
Post Question What factors should be considered when justifying sustainable primary
care pharmacy services?a) Understand the unique characteristics of the surrounding community to
support expanded pharmacy services
b) Align proposed services with the clinical and financial priorities of the organization
c) Ensure payments for pharmacy services are within the scope of the organization’s reimbursement structure
d) Ensure a sustainable infrastructure of support is included in the proposal, including staffing levels, anticipated growth, shifts in payments, and future technology costs
e) All of the above
References Centers for Medicare and Medicaid Services. Providing the
annual wellness visit (AWV). www.cms.gov/ Desselle SP, Zgarrick DP. Pharmacy management: essentials for
all practice settings. 2nd ed. New York: McGraw Hill Medical, 2009.
Warshany K, Sherrill CH, Cavanaugh J, et al. Medicare annual wellness visits conducted by a pharmacist in an internal medicine clinic. Am J Health Syst Pharm. 2014 Jan 1;71(1):44-9.
Questions?
Medicare Part B licensureEvaluating its potential in a federally qualified health
center (FQHC) outpatient pharmacy system
Kari London, PharmD PGY-1 Community Pharmacy Practice ResidentPenobscot Community Heath CareApril 26th, 2014
Objective Understand the barriers and benefits of DME
Supplier enrollment in the independent pharmacy setting– Focus: Diabetic testing supplies
Background• From 1980 to 2004 the number of people age 65
years and older diagnosed with diabetes increased almost two fold, from 2.3 million to 5.8 million1
• Prescription medications to treat diabetic complications, and antidiabetic agents plus testing supplies, are two of the largest drivers of expense at 18% and 12%, respectively2
• Medicare Part B coverage is an important means of mitigating prescription costs of these products
Background cont.• FQHC with 16 primary care practice sites • Pharmacy services• 3 outpatient pharmacies, residency program,
faculty practice sites, pharmacy students• Exploring feasibility of piloting DME
supplier enrollment at one pharmacy• Primary products on interest: diabetic testing
supplies
Barriers Program administrative costs
Per Site (USD) Medicare DMEPOS Enrollment Fee 532 NABP DMEPOS Accreditation Fees
Application and Survey Fees 3250 Annual Participation Fee 125 Year 1 subtotal 3375 Estimated total for 3-year accreditation 3625
Surety Bond (annual fee) 1200 Estimated Total Fees
Year 1 5107
Year 1-3 Total 7757
Barriers cont. Program infrastructure– Software systems– Documentation requirements– Employee training– Inventory management
Barriers Cont. Patient recruitment– Eligible patient population size
Low product reimbursement
80.1%
19.9%Other pharmacies
PCHC pharmacies 81.3%
18.7%
Total Patient Capture Diabetic Patient Capture
50ct Test Strips 100ct Lancets BG Monitor Prescription
Medicare reimbursement $10.41 $2.52 $72.34 ------------
Average Revenue -$42.86 -$5.10 $51.06 -$324.18
Benefits Improved patient recruitment– The “Loss Leader”– i.e. gross ~$7,000/year of revenue on prescriptions for 1
patient Increased services Improved patient care– Patient Centered Medical Home– Coordination of care
The Numbers Revenue per diabetic pt. / year
Series1
$1,464
$2,112
$(648)
Testing Supplies RXs Other RXs Total Revenue
The Numbers cont. Revenue projection
Year 1 Average / Year Cumulative Years 1-3
$(8,000)
$(6,000)
$(4,000)
$(2,000)
$-
$2,000
$4,000
$6,000
$(5,107)
$(2,585)
$(7,757)
$2,050 $2,050
$6,150
$(3,057)
$(535)
$(1,607)
Administrative Costs
Potential DM Pt. Revenue
Net Revenue
Conclusions Administrative costs of implementing Medicare Part B billing pose
the most significant barrier to program feasibility
Potential increase in capture of non-diabetic supply prescriptions may be sufficient to mitigate losses associated with filling diabetic testing supply prescriptions
Being a participating DME supplier for diabetic testing supplies presents a negligible loss ($535/ pharmacy/year)
– Utilized conservative patient capture increase numbers and high estimate of revenue loss of diabetic supplies
– Did not account for potential revenue loss from lost patients
References1. Ashkenazy R, Abrahamson MJ. Medicare coverage for
patients with diabetes. A national plan with individual consequences. J Gen Intern Med. 2006 Apr;21(4):386-92.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013; 36 (4): 1033-46.
3. DMEPOS. NABP National Association of Boards of Pharmacy. Website. http://www.nabp.net/programs/accreditation/dmepos. Accessed November 29th, 2013
4. NHIC, Corporation. The DME MAC Jurisdiction A Supplier Manual. Website. http://www.medicarenhic.com/dme/supmandownload.aspx. Accessed December 6th, 2013.
Post questionPotential threats to the success of Medicare Part B DME program for this FQHC pharmacy system include:
A. Low product reimbursementsB. High administrative costsC. Documentation requirementsD. Eligible patient population sizeE. All of the Above
Questions?
Impact of a interdisciplinary team approach in the treatment of high risk patients with chronic obstructive pulmonary disease (COPD):
A pilot program in the primary care settingZach Deabay, PharmD
Penobscot Community Health Care
PGY1 Pharmacy Practice Residents
April 26th, 2014
Objectives Discuss the interdisciplinary team approach in the
management of COPD Evaluate strategies utilized to improve disease state
management and access to medications Analyze effect of the program on healthcare utilization
and strategies moving forward
Disclosure: Study funded by grant received from Cardinal Health. Did not influence implementation, execution, or analysis of study.
Background• Prevalence of COPD in the US is estimated at 23.6 million adults1
• Medicare patient with COPD have higher rates of hospitalization, ER visits, and home healthcare use than non-COPD peers2
• Total excess healthcare costs of ~$20,000/year higher
• ~80% due to inpatient services• Studies looking at efficacy of self-management interventions to
improve COPD management have demonstrated mixed results3,4
Overview Components of Program
– Education session with care manager and pharmacist
– Rescue Pack
• Providers choice of antibiotic +/- steroid for patients to keep at home
• Patient must contact care manager or provider before use
Goals– Educate patient to better self-manage disease state
– Optimize therapeutic regimen
– Provider easier/quicker medication access to reduce severity of COPD exacerbation
Workflow Pre-visit
– Chart review by care manager
– Pharmacotherapy review by pharmacist
• Recommendations made to provider
Visit– Disease state assessment, education, and management techniques
– Comprehensive medication assessment
• Technique, compliance, barriers, perception
Post-visit– Care management follow-up
– Rescue pack
Program Materials
Target PopulationDocumented COPD exacerbation in prior
12 months prompting patient to seek acute
medical attention(Emergency Department, Walk-In Care, Office Visit)
COPD Diagnosis
Other Inclusion Criteria• Patient desire to participate• Patient attendance of educational visit
Exclusion Criteria• History of non-compliance• Comorbidity affecting ability to self-
manage disease state
Inclusion Criteria Met
Approval of PCP
Education Visit
Pre-visit Protocol
Enrollment First patient enrolled 8/29/13 Enrollment ongoing 52 patients enrolled to date
– Current Smoker – 49%
– Average # Medications – 10
– Average # Respiratory Medications – 3
– Oxygen Therapy – 20%
– Females – 32 (62%)
– Males – 20 (38%)
– Age
• Range – 42-91 years
• Average – 65 years
Result Analysis Patients required to be
in study a minimum of 3 months before analysis performed
26 patients meet this criteria – Additional 11 patients
qualify in May
Analysis will include:– Primary endpoints
• Hospitalizations
• Use of emergency department and walk-in services
• Death
– Secondary endpoints• Rescue pack use
(appropriate/inappropriate)
• Number of exacerbations
Preliminary Observations Majority of patients enrolled in program are prescribed rescue
pack (>80%) Of those prescribed rescue packs, most have not used them
(<50%) Most commonly prescribed combination is
azithromycin/prednisone Several patients have used the rescue packs inappropriately
but majority of uses (>75%) have been appropriate Program appears to be reducing utilization of emergency room
– Possible shift from decreased ER visits to increased office visits
Program Benefit Organization Benefits
Patient care divided among team members
Accurate medication list Assessment of medication
compliance Pharmacotherapy review Improved patient
outcomes* Lower healthcare costs*
Patient Benefits Disease state education Medication education Pharmacotherapy
review Relationship with care
manager Easier access to
medication
*Being assessed in current study
Patient Case
After CM visit reports recognition of symptoms that warrant appt. Lack of maintenance medication identified at visit with follow-up recommended
Patient call: states "been having more shortness of breath and burning in chest, which is always the first sign of the bronchitis."
Patient initiated antibiotic and steroid, with PCP follow-up visit within several days. Instructed to call back for appointment if symptoms do not improve.
Follow-up office visit: “patient reluctant in gen to take meds but with recent exacerbation she started the pack and did much better than usual, recovering more quickly from COPD exac.”
56 yof with COPD, typically waits if she is sick
Key Points Interdisciplinary approaches utilize the expertise of all
healthcare team members Rescue packs provide quicker and easier access to
medication and may be a useful tool, if used appropriately It is essential to do educational visit Before rescue pack
medications are sent to pharmacy Difficult to predict which patients are most appropriate for
rescue packs– All patients expected to benefit from educational component
Assessment QuestionBenefits of enrollment in the COPD program include all of the following except:
A. Medication and disease state education
B. Patient ability to decide when their symptoms warrant antibiotic therapy
C. Quicker access to medications if deemed appropriate by provider
D. All of these are benefits of the program
References1. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive
pulmonary disease. Proc Am Thorac Soc. 2007; 4 (7): 502-6.2. Make B, Dutro MP, Paulose-Ram R, Marton JP, Mapel DW. Undertreatment of COPD: a
retrospective analysis of US managed care and Medicare patients. Int J Chron Obstruct Pulmon Dis. 2012; 7: 1-9.
3. Effing T, Monninkhof EEM, van der Valk PP, et al. Self-management education for patients with chronic obstructive pulmonary disease (Review). Cochrane Database Systm Rev. 2009
4. Bucknall CE, Miller G, Lloyd SM, et al. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomized controlled trial. BMJ 2012; 344: e1060 doi: 10.1136/bmj.e1060
5. London, Kari. Chronic obstructive pulmonary disease management in high risk patients: Evaluation of a multidisciplinary team approach to reduce readmission rates within a federally qualified health center population. MSHP Conference. Jan 26, 2014.
Questions?
Pharmacist Interventions on Prescribing Habits for Urinary Tract Infections (UTIs) in a Walk-In Care ClinicNicholas LeBlanc, PharmDPGY1 Pharmacy ResidentPenobscot Community Health Care
Objective Identify trends in antibiotic resistance of urinary
tract infections and formulate a plan to reduce inappropriate prescribing of antibiotics.
Introduction Uncomplicated cystitis is a very common infection among
young women and a major source of antimicrobial exposure.
Repeated antimicrobial exposure can select for resistant organisms.
Antimicrobial resistance has complicated treatment of urinary tract infections.
Community pharmacists can play a role in lowering resistance.
Guidelines First-line agents are Nitrofurantoin, Trimethoprim-
Sulfamethoxazole (Bactrim), and Fosfomycin. TMP-SMX should not be used empirically if local
resistance is greater than 20%. Second-line agents are fluoroquinolones and β-lactams.
Fluoroquinolones should not be used empirically if local resistance is greater than 10%.
Local Resistances
Local Resistances
UTI Prescription Analysis A 6 month time period was analyzed. Reviewed antimicrobial prescriptions associated
with ICD-9 code 599.0 (UTI). Inappropriate medications were omitted:– Azithromycin– Doxycycline– Metronidazole
Initial Results Penicillins9%
TMP-SMX29%
Cephalosporins5%
Fluoro-quinolones
33%
Tetracyclines3%
Nitrofurantoin20%
Antimicrobial Agents
Discussion A total of 1315 prescriptions were analyzed. Approximately half of the prescriptions analyzed
were for non-first line agents. Fluoroquinolones were the most highly
prescribed antimicrobial class (33.38%). Penicillins, cephalosporins, and tetracyclines
were sparsely prescribed.
Limitations ICD-9 codes do not describe the patient well. The data does not distinguish whether the UTI
was treated empirically or not. Tetracycline use may not have been associated
with UTIs.
Role of the Pharmacist Community pharmacists can serve as a source of information for providers.
– Up to date on guidelines– Drug experts– Useful resources
Giving feedback to providers on prescribing habits. Provider education
– CME presentations– Calling about errors in prescriptions– Group meetings– Handouts– EMR alerts– Get feedback from providers
Conclusion Antimicrobial resistance is low, but prescribing
habits leave much room for improvement. Pharmacists can be a valuable resource of drug
information and provide education to providers. There are many different ways in which
pharmacists may educate providers.
References Gupta K, Hooton TM, Naber KG, et al. International Clinical Practice
Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011; 52(5):e103–20.
Gupta K, Hooton TM, Stamm WE. Increasing Antimicrobial Resistance and the Management of Uncomplicated Community-Acquired Urinary Tract Infections. Ann Intern Med. 2001;135(1):41-50.
Hooton T, Gupta K. Acute Uncomplicated Cystitis and Pyelonephritis in Women. UpToDate. 2013.
Assessment QuestionsWhich of the following is an appropriate way to reduce
resistance of urinary tract infection organisms by pharmacists?
A. Ensure proper prescribing of first-line agentsB. Antimicrobial stewardship programsC. Keeping providers up to date on current guidelinesD. Be a resource of drug information for providersE. All of the above are true
Questions?
Implementation and outcomes of an interdisciplinary collaborative practice group on controlled substance use and prescribing
within a patient-centered medical home Rachel Bastien, PharmD
PGY1 Resident, Penobscot Community Health CareBangor, ME
Objective Summarize the development, workflow, and
pharmacist involvement of the Controlled Substances Initiative (CSI) committee and evaluate the impact on providers, patients, pharmacy dispensing, and prescribing habits.Disclosure Authors of this presentation have the following to disclose concerning possible financial or personal
relationships with commercial entities that may have a direct or indirect interest in the subject matter of this presentation:
Rachel Bastien: Nothing to disclose
Motivation Increasing rates of prescription drug abuse The cost to the overall health of patients and the
community Negative social impact Increased costs associated with abuse Provider frustrations
Development Formed in March 2013 Initially, the committee members were appointed by the executive
medical director– Executive medical director– Chief quality officer– Chief psychiatrist– Physicians– Nurse practitioners
Soon after pharmacists were added for their drug expertise Weekly meetings where approximately 8-12 patients are reviewed
Workflow
1 •Referral to CSI
2 •Pharmacist conducts a comprehensive chart review
3 •Pharmacist presents patient case from chart review to committee
4 •Collaborative interdisciplinary discussion generates targeted, evidence-based recommendations with action plans
5 •Consensus recommendations communicated to provider
6 •Review and appeal process
The Role of the Pharmacist Pharmacist conducts a comprehensive chart review, including
– Maine Prescription Monitoring Program (PMP) report– Health Info Net– Office visit notes – Consults with specialists – Medication history – Imaging studies – Any additional pertinent information – Calculate Morphine Equivalent Dose (MED)
Presents case to committee Communicates responses to providers
Population reviewed
Outcomes
24%
39%
32%
5%
Percentage of patients with MED changes post CSI review
Off of narcotics entirely (N = 21)
Reduced dose (N = 34)
No change (N = 28)
Dose increase (N = 4)
Outcomes
June July August 1750
1800
1850
1900
1950
2000
2050
2100
2150
2200
Narcotic and Benzodiazepine prescriptions written organization wide
20122013
Month
Num
ber o
f pre
scrip
tions
Outcomes Number of prescriptions filled at largest-volume internal outpatient pharmacy
2012 (June-Aug) 2013 (June-Aug) CIITotal 1514 1245 (-17.7%) Opiates 673 606 (-9.9%) Stimulants 841 639 (-24%)
CIII-VTotal 1307 1080 (-17.3%) Benzodiazepine 433 350 (-19.1%) Codeine/Hydrocodone Products 392 296 (-24.4%) Buprenorphine Products 265 281 (+6%) Hypnotics 127 93 (-26.7%) Other (Lyrica, Soma, Testosterone, etc.)
90 60 (-33.3%)
Challenges and opportunities Presenting alternative treatments to providers – Use of NSAIDs, SSRIs, therapy, etc where appropriate
Challenges within PCHC prescribing trends – Increase prescribing of tramadol and ketorolac
Engaging the entire healthcare team – Physical therapy – OMT– Addiction services
Discussion An overall 63% reduction in MED occurred in patients reviewed by the
committee A 12% reduction in the number of opioid prescriptions written occurred
between January and September 2013 The largest of the 3 internal outpatient pharmacies saw a 17.7%
decrease in the number of C-II prescriptions filled
Takeaway points Provides provider support and education Defines clear expectations for both patients and prescribers Allows for objective and evidence-based use of controlled medications
Assessment question As a result of instituting a controlled substances
committee, which of the following was not directly enhanced?1. Multidisciplinary collaboration
2. Patient acceptance of need for dose reduction
3. Chapter 21 compliance measures
4. Provider prescribing support
Questions?